
Exploring the Impact of the 21st Century Cures Act

Patient-Centric Initiatives: Focusing for Impact

A New Imperative for Private Research Funders

Expanding the Science of Patient Input: Pain Points and Potential

Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders

GBM: Giving Smarter

Patient-Reported Outcomes: Design with the End in Mind

Ep. 96: Transitions, with the Peter MacCallum Cancer Centre’s Michael Hofman

Mobilizing Stalled Assets from Big Pharma for Neglected Patient Groups
